tradingkey.logo
搜索

FibroGen Ord Shs

KYNB
添加自选
7.250USD
-0.030-0.41%
收盘 09-23 16:00美东
29.36M总市值
0.18市盈率 TTM

关于 公司

FibroGen Ord Shs 简介

公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -

FibroGen Ord Shs公司高管

名称
名称/职务
职务
持股
持股变动
Mr. James A. (Jim) Schoeneck
Mr. James A. (Jim) Schoeneck
Independent Chairman of the Board
Independent Chairman of the Board
39.67K
+59.41%
Mr. James A. (Jim) Schoeneck
Mr. James A. (Jim) Schoeneck
Independent Chairman of the Board
Independent Chairman of the Board
39.67K
+59.41%
Mr. Thane Wettig
Mr. Thane Wettig
Chief Executive Officer, Director
Chief Executive Officer, Director
23.54K
-0.89%
Mr. Thane Wettig
Mr. Thane Wettig
Chief Executive Officer, Director
Chief Executive Officer, Director
23.54K
-0.89%
Mr. David Delucia
Mr. David Delucia
Chief Financial Officer
Chief Financial Officer
4.03K
-0.55%
Mr. David Delucia
Mr. David Delucia
Chief Financial Officer
Chief Financial Officer
4.03K
-0.55%
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
1.36K
--
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
1.36K
--
Dr. Maykin Ho, Ph.D.
Dr. Maykin Ho, Ph.D.
Independent Director
Independent Director
1.26K
--
Dr. Maykin Ho, Ph.D.
Dr. Maykin Ho, Ph.D.
Independent Director
Independent Director
1.26K
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. James A. (Jim) Schoeneck
Mr. James A. (Jim) Schoeneck
Independent Chairman of the Board
Independent Chairman of the Board
39.67K
+59.41%
Mr. James A. (Jim) Schoeneck
Mr. James A. (Jim) Schoeneck
Independent Chairman of the Board
Independent Chairman of the Board
39.67K
+59.41%
Mr. Thane Wettig
Mr. Thane Wettig
Chief Executive Officer, Director
Chief Executive Officer, Director
23.54K
-0.89%
Mr. Thane Wettig
Mr. Thane Wettig
Chief Executive Officer, Director
Chief Executive Officer, Director
23.54K
-0.89%
Mr. David Delucia
Mr. David Delucia
Chief Financial Officer
Chief Financial Officer
4.03K
-0.55%
Mr. David Delucia
Mr. David Delucia
Chief Financial Officer
Chief Financial Officer
4.03K
-0.55%

常见问题

FibroGen Ord Shs的前五大股东是谁?

FibroGen Ord Shs 的前五大股东如下:Mr. James A. (Jim) Schoeneck

有多少机构持有FibroGen Ord Shs(KYNB)的股份?

截至2026Q1,共有184家机构持有FibroGen Ord Shs的股份,合计持有的股份价值约为1.35M,占公司总股份的33.36%。与2025Q4相比,机构持股有所增加,增幅为-396059.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有